Joshua Kazam
2018
In 2018, Joshua Kazam earned a total compensation of $3.6M as Former President at Allogene Therapeutics.
Compensation breakdown
| Stock Awards | $3,592,474 |
|---|---|
| Total | $3,592,474 |
Kazam received $3.6M in stock awards, accounting for 100% of the total pay in 2018.
Rankings
In 2018, Joshua Kazam's compensation ranked 3,152nd out of 14,244 executives tracked by ExecPay. In other words, Kazam earned more than 77.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,152 out of 14,244 | 78th |
Division Manufacturing | 1,171 out of 5,765 | 80th |
Major group Chemicals And Allied Products | 409 out of 2,128 | 81st |
Industry group Drugs | 338 out of 1,817 | 81st |
Industry Biological Products, Except Diagnostic Substances | 73 out of 339 | 79th |
Source: SEC filing on April 24, 2019.
Kazam's colleagues
We found three more compensation records of executives who worked with Joshua Kazam at Allogene Therapeutics in 2018.